Merck & Co has posted a net income of $1.77 billion for the second quarter of 2008, compared with $1.68 billion for the corresponding period of 2007.
Subscribe to our email newsletter
Worldwide sales were $6.1 billion in the second quarter of 2008, a decrease of 1% from the second quarter of 2007. For the first six months of 2008, worldwide sales were $11.9 billion and net income was $5.07 billion.
Richard Clark, chairman, president and CEO of Merck, said: “For the second quarter, Merck made good progress launching innovative new pharmaceutical and vaccine products around the world and driving efficiencies in many parts of the business. Although some results didn’t meet our expectations, we are taking action to address our challenges, and remain committed to regaining leadership in the pharmaceutical industry.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.